These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29693539)

  • 1. We all know what we mean by treatment-resistant depression - don't we?
    Anderson IM
    Br J Psychiatry; 2018 May; 212(5):259-261. PubMed ID: 29693539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the care of patients who have treatment-resistant depression: the promise of the PCORnet Mood Network.
    Nierenberg AA; Sylvia L; Doederlein A; Edgman-Levitan S; Muskin A; Jewell L; Walker M; Goodman D; Farahbakhsh M; Hearing C; Tovey R; Deckersbach T
    J Clin Psychiatry; 2015 Apr; 76(4):e528-30. PubMed ID: 25919850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
    Husain MI; Chaudhry IB; Husain N; Khoso AB; Rahman RR; Hamirani MM; Hodsoll J; Qurashi I; Deakin JF; Young AH
    J Psychopharmacol; 2017 Sep; 31(9):1166-1175. PubMed ID: 28857658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of Treatment-resistant Depression.
    Pandarakalam JP
    Psychiatr Danub; 2018 Sep; 30(3):273-284. PubMed ID: 30267518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
    Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
    J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study.
    Li CT; Bai YM; Huang YL; Chen YS; Chen TJ; Cheng JY; Su TP
    Br J Psychiatry; 2012 Jan; 200(1):45-51. PubMed ID: 22016435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among patients with major depression: A nationwide longitudinal study.
    Chen MH; Pan TL; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Chang WH; Chen TJ; Bai YM
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1760-1767. PubMed ID: 27667705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.
    Thase ME; Youakim JM; Skuban A; Hobart M; Augustine C; Zhang P; McQuade RD; Carson WH; Nyilas M; Sanchez R; Eriksson H
    J Clin Psychiatry; 2015 Sep; 76(9):1224-31. PubMed ID: 26301701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
    Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
    Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating depression with adjunctive antipsychotics.
    Mulder R; Hamilton A; Irwin L; Boyce P; Morris G; Porter RJ; Malhi GS
    Bipolar Disord; 2018 Nov; 20 Suppl 2():17-24. PubMed ID: 30328223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant augmentation: good news, limitations, and stumbling blocks.
    Kocsis JH
    J Clin Psychiatry; 2015 Apr; 76(4):e526-7. PubMed ID: 25919849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-therapy-resistant major depressive disorder: a clinically important concept.
    McAllister-Williams RH; Christmas DMB; Cleare AJ; Currie A; Gledhill J; Insole L; Malizia AL; McGeever M; Morriss R; Robinson LJ; Scott M; Stokes PRA; Talbot PS; Young AH
    Br J Psychiatry; 2018 May; 212(5):274-278. PubMed ID: 30517072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous ketamine infusion for a patient with treatment-resistant major depression: a 10-month follow-up.
    Kwon JH; Sim WS; Hong JP; Song IS; Lee JY
    J Clin Pharm Ther; 2018 Aug; 43(4):581-583. PubMed ID: 29372569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of Major Depressive Disorder With Add-On Buprenorphine in a Patient With Previous Nonresponse to Standard Antidepressants.
    Elsayed M; Gahr M; Connemann BJ; Schönfeldt-Lecuona C
    Prim Care Companion CNS Disord; 2017 Sep; 19(5):. PubMed ID: 28972704
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjunctive medication strategies for treatment-resistant depression.
    Lam RW
    Can J Psychiatry; 2011 Jun; 56(6):315-6. PubMed ID: 21756444
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
    Fava M; Okame T; Matsushima Y; Perry P; Weiller E; Baker RA
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):22-30. PubMed ID: 27784751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the comparative benefits and harms of augmentation treatments in major depression?
    Shelton RC
    J Clin Psychiatry; 2015 Apr; 76(4):e531-3. PubMed ID: 25919851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.